Glyburide inhibits the Cryopyrin/Nalp3 inflammasome

Gout-associated uric acid crystals activate the NALP3 inflammasome

Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326

Cryopyrin activates the inflammasome in response to toxins and ATP

Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065

Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica

Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658

The NALP3 inflammasome is involved in the innate immune response to amyloid-β

Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. L., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,864

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome

Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001) · Nature Genetics · doi:10.1038/ng756 · Cited by 1,679

Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor

Pelegrı́n, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,490

Cloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion

Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

Kanneganti, T., Özören, N., Body–Malapel, M., Amer, A. O., Park, J., Franchi, L., Whitfield, J. R., Barchet, W., Colonna, M., Vandenabeele, P., et al. (2006) · Nature · doi:10.1038/nature04517 · Cited by 1,149

A Genetically Encoded IL-1β Bioluminescence Resonance Energy Transfer Sensor To Monitor Inflammasome Activity

Compan, V., Baroja‐Mazo, A., Bragg, L., Verkhratsky, A., Perroy, J., & Pelegrı́n, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201349 · Cited by 27

General Strategies in Inflammasome Biology

Dubois, H., Wullaert, A., & Lamkanfi, M. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_1 · Cited by 26

Plausible anti-inflammatory mechanism of resveratrol and caffeic acid against chronic stress-induced insulin resistance in mice

Choudhary, S., Mourya, A., Ahuja, S., Sah, S. P., & Kumar, A. (2016) · Inflammopharmacology · doi:10.1007/s10787-016-0287-y · Cited by 24

Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides

Pal, A., Neo, K., Lakshminarayanan, R., Ferrer, F. J., Lane, D. P., Verma, C. S., & Mortellaro, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41211-3 · Cited by 24

Advances in Inflammasome Research: Recent Breakthroughs and Future Hurdles

Tweedell, R. E., & Kanneganti, T. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.07.010 · Cited by 24

Discovery of carbon-11 labeled sulfonamide derivative: A PET tracer for imaging brain NLRP3 inflammasome

Xu, Y., Xu, Y., Blevins, H., Lan, Y., Liu, Y., Yuan, G., Striar, R., Zagaroli, J. S., Tocci, D. R., Langan, A. G., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127777 · Cited by 24

Inflammasomes in the urinary tract: a disease-based review

Purves, J. T., & Hughes, F. M. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00607.2015 · Cited by 24

The NEK-sus of the NLRP3 inflammasome

Hauwermeiren, F. V., & Lamkanfi, M. (2016) · Nature Immunology · doi:10.1038/ni.3391 · Cited by 23

NLRP3 Inflammasome in Inflammation and Metabolism: Identifying Novel Roles in Postburn Adipose Dysfunction

Vinaik, R., Barayan, D., & Jeschke, M. G. (2020) · Endocrinology · doi:10.1210/endocr/bqaa116 · Cited by 23

Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation

Al-Saadi, A., Tezcan, G., Garanina, E. E., Hamza, S., McIntyre, A., Rizvanov, A. A., & Khaiboullina, S. F. (2021) · Pharmaceuticals · doi:10.3390/ph14090852 · Cited by 23

Walking down Skeletal Muscle Lane: From Inflammasome to Disease

Dubuisson, N., Versele, R., de Carrizosa, M. A. D., Selvais, C. M., Brichard, S. M., & Abou‐Samra, M. (2021) · Cells · doi:10.3390/cells10113023 · Cited by 23

Dysregulation of inflammasome activation in glioma

Sim, J., Park, J., Moon, J., & Lim, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01255-5 · Cited by 24

NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease

Zhang, J., Zeng, S., Wang, P., Chen, Y., & Zeng, C. (2023) · Current Drug Targets · doi:10.2174/0113894501255960231101105113 · Cited by 25

Bovine herpesvirus 1 productive infection stimulates inflammasome formation and caspase 1 activity

Wang, J., Alexander, J., Wiebe, M. S., & Jones, C. (2014) · Virus Research · doi:10.1016/j.virusres.2014.03.006 · Cited by 23

Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action

Wilhelmsen, K., Deshpande, A., Tronnes, S. U., Mahanta, M., BANICKI, M., COCHRAN, M., Cowdin, S., Fortney, K., Hartman, G. D., Hughes, R. E., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20242403 · Cited by 22

Identification of NLRP3PYD Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity

Ghafary, S. M., Soriano‐Teruel, P. M., Lotfollahzadeh, S., Sancho, M., Serrano‐Candelas, E., Karami, F., Barigye, S. J., Fernández-Pérez, I., Gozalbes, R., Nikkhah, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031651 · Cited by 23

Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway

Jie, Y., Yang, J., Huang, X., Xiu, H., Bai, S., Li, J., Cai, Z., Chen, Z., Zhang, S., & Zhang, G. (2022) · Mediators of Inflammation · doi:10.1155/2022/8457010 · Cited by 22

Differences in Inflammatory Response Induced by Two Representatives of Clades of the Pandemic ST258 Klebsiella pneumoniae Clonal Lineage Producing KPC-Type Carbapenemases

Castronovo, G., Clemente, A. M., Antonelli, A., D’Andrea, M. M., Tanturli, M., Perissi, E., Paccosi, S., Parenti, A., Cozzolino, F., Rossolini, G. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170125 · Cited by 22

Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer’s Disease

Xie, J., Wang, H., Lin, T., & Bi, B. (2017) · BioMed Research International · doi:10.1155/2017/2986460 · Cited by 22

Aeromonas sobria Induces Proinflammatory Cytokines Production in Mouse Macrophages via Activating NLRP3 Inflammasome Signaling Pathways

Zhang, W. K., Li, Z., Yang, H., Wang, G., Liu, G., Wang, Y., Bello, B. K., Zhao, P., Liang, W., & Dong, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.691445 · Cited by 21

Inflammasomes: Cause or consequence of obesity‐associated comorbidities in humans

Herrera-Martínez, A. D., Herrero‐Aguayo, V., Pérez‐Gómez, J. M., Gahete, M. D., & Luque, R. M. (2022) · Obesity · doi:10.1002/oby.23581 · Cited by 22

The Mechanism of Pyroptosis and Its Application Prospect in Diabetic Wound Healing

Mamun, A. A., Shao, C., Geng, P., Wang, S., & Xiao, J. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s448693 · Cited by 22

Dental Calculus Stimulates Interleukin-1β Secretion by Activating NLRP3 Inflammasome in Human and Mouse Phagocytes

Raudales, J. L. M., Yoshimura, A., Ziauddin, S. M., Kaneko, T., Ozaki, Y., Ukai, T., Miyazaki, T., Latz, E., & Hara, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162865 · Cited by 21

Discovery and optimization of 4-oxo-2-thioxo-thiazolidinones as NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inhibitors

Chen, Y., He, H., Jiang, H., Li, L., Hu, Z., Huang, H., Xu, Q., Zhou, R., & Deng, X. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127021 · Cited by 21

Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation

Challagundla, N., Saha, B., & Agrawal-Rajput, R. (2022) · Immunologic Research · doi:10.1007/s12026-022-09286-9 · Cited by 22

Decoding NLRP3 Inflammasome Activation in Alzheimer’s Disease: A Focus on Receptor Dynamics

Maurya, R., Sharma, A., & Naqvi, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04918-1 · Cited by 22

Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway

Chen, H., Ding, Y., Chen, W., Feng, Y., & Shi, G. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s196040 · Cited by 20

Role of NLRP3 Inflammasome in Stroke Pathobiology: Current Therapeutic Avenues and Future Perspective

Panbhare, K., Pandey, R., Chauhan, C., Sinha, A., Shukla, R., & Kaundal, R. K. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00536 · Cited by 21

Stress-Induced NLRP3 Inflammasome in Human Diseases

Alcocer‐Gómez, E., Castejón‐Vega, B., & Cordero, M. D. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.02.002 · Cited by 19

Dysregulation of Gap Junction Function and Cytokine Production in Response to Non-Genotoxic Polycyclic Aromatic Hydrocarbons in an In Vitro Lung Cell Model

Romo, D., Velmurugan, K., Upham, B. L., Dwyer‐Nield, L. D., & Bauer, A. K. (2019) · Cancers · doi:10.3390/cancers11040572 · Cited by 20

Inflammasome Priming Is Similar for Francisella Species That Differentially Induce Inflammasome Activation

Ghonime, M. G., Mitra, S., El-Domany, R. A., Wewers, M. D., & Gavrilin, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127278 · Cited by 18

Host-directed Therapy: A New Arsenal to Come

Mohan, M., & Bhattacharya, D. (2020) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207323999200728115857 · Cited by 19

Techniques to Study Inflammasome Activation and Inhibition by Small Molecules

Angosto-Bazarra, D., Molina‐López, C., Peñín‐Franch, A., Hurtado‐Navarro, L., & Pelegrín, P. (2021) · Molecules · doi:10.3390/molecules26061704 · Cited by 19

Regulation of crystal induced inflammation: current understandings and clinical implications

Galozzi, P., Bindoli, S., Luisetto, R., Sfriso, P., Ramonda, R., Scanu, A., & Oliviero, F. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1937129 · Cited by 19

Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases

Shi, C., Zhang, X., Chi, X., Zhou, Y. R., Lyu, W., Gao, T., Zhou, J., Chen, Y., Yi, C., Sun, X., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115784 · Cited by 19

Discovery of Novel 2,3-Dihydro-1H-indene-5-sulfonamide NLRP3 Inflammasome Inhibitors Targeting Colon as a Potential Therapy for Colitis

Sun, S., Li, Z., Huang, C., Liu, J., Yu, Q., Jiang, X., Yue, K., Zhao, J., Xu, T., Liu, Y., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01511 · Cited by 19

Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold

Xu, Y., Xu, Y., Biby, S., Kaur, B., Liu, Y., Bagdasarian, F. A., Wey, H., Tanzi, R. E., Zhang, C. M., Wang, C., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01782 · Cited by 19

Discovery of benzo[cd]indol-2-one and benzylidene-thiazolidine-2,4-dione as new classes of NLRP3 inflammasome inhibitors via ER-β structure based virtual screening

Abdullaha, M., Ali, M., Kour, D., Kumar, A., & Bharate, S. B. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103500 · Cited by 19

Glibenclamide reduces proinflammatory cytokines in an ex vivo model of human endotoxinaemia under hypoxaemic conditions

Schmid, D., Svoboda, M., Sorgner, A., Moravcevic, I., Thalhammer, T., Chiba, P., & Moeslinger, T. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.08.017 · Cited by 19

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort

Balagopal, A., Gupte, N., Shivakoti, R., Cox, A. L., Yang, W.-T., Berendes, S., Mwelase, N., Kanyama, C., Pillay, S., Samaneka, W. P., et al. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw118 · Cited by 19

Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy

Yin, K., Zhang, Z., Mo, Y., Wu, H., Cao, Z., Xue, Y., Wang, M., Guo, W., Feng, L., Zhao, C., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116581 · Cited by 19

Discovery of Potent and Brain-Penetrant Bicyclic NLRP3 Inhibitors with Peripheral and Central In Vivo Activity

Mammoliti, O., Carbajo, R. J., Pérez‐Benito, L., Yu, X., Prieri, M., Bontempi, L., Embrechts, S., Paesmans, I., Bassi, M., Bhattacharya, A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03108 · Cited by 18

Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS

Zhang, M., Shang, L., Zhou, F., Cai, Y., Wang, S., Li, J., Liu, Y., Huang, J., & Yang, S. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02168-z · Cited by 21

Neuroprotection of NSC Therapy is Superior to Glibenclamide in Cardiac Arrest-Induced Brain Injury via Neuroinflammation Regulation

Wang, Z., Zhang, S., Du, J., Lachance, B. B., Chen, S., Polster, B. M., & Jia, X. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01047-y · Cited by 18

Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer

Wang, X., Lin, J., Wang, Z., Li, Z., & Wang, M. (2023) · Discover Oncology · doi:10.1007/s12672-023-00701-7 · Cited by 20

High glucose enhances the activation of NLRP3 inflammasome by ambient fine particulate matter in alveolar macrophages

Mo, Y., Mo, L., Zhang, Y., Zhang, Y., Yuan, J., & Zhang, Q. (2023) · Particle and Fibre Toxicology · doi:10.1186/s12989-023-00552-8 · Cited by 18

The Role of Inflammasome in Abdominal Aortic Aneurysm and Its Potential Drugs

Pi, S., Xiong, S., Yuan, Y., & Deng, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095001 · Cited by 18

Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy

Li, L., Chen, L., & Sun, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122951 · Cited by 18

NLRP3/IL‐1β mediates denervation during bladder outlet obstruction in rats

Lütolf, R., Hughes, F. M., Inouye, B. M., Jin, H., McMains, J. C., Pak, E. S., Hannan, J. L., & Purves, J. T. (2017) · Neurourology and Urodynamics · doi:10.1002/nau.23419 · Cited by 18

Inflammasome-Independent NALP3 Contributes to High-Salt Induced Endothelial Dysfunction

Fu, H., Chen, J., Lu, W., Jiang, Y., Wang, Y.-Y., Li, D., & Shen, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00968 · Cited by 18

Inflammasome inhibition blocks cardiac glycoside cell toxicity

LaRock, D. L., Sands, J. S., Ettouati, E., Richard, M., Bushway, P., ADLER, E. D., Nizet, V., & LaRock, C. N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008330 · Cited by 16

The pore-forming subunit Kir6.1 of the K-ATP channel negatively regulates the NLRP3 inflammasome to control insulin resistance by interacting with NLRP3

Du, R., Lu, M., Wang, C., Ding, J.-H., Wu, G., & Hu, G. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0291-6 · Cited by 18

Glyburide attenuates ozone‐induced pulmonary inflammation and injury by blocking the NLRP3 inflammasome

Shao, H., Huang, L., Duan, S., Gao, M., Zhu, J., Chen, X., Zhu, Y., Wang, W., Yang, Z., Wang, X., et al. (2020) · Environmental Toxicology · doi:10.1002/tox.22919 · Cited by 18

NLRP3 Inflammasome: a Novel Insight into Heart Failure

Wang, Y., Li, Y., Zhang, W., Yuan, Z., Lv, S., & Zhang, J. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10286-1 · Cited by 19

Application of immobilized ATP to the study of NLRP inflammasomes

Liao, K., Sandall, C. F., Carlson, D. A., Ulke‐Lemée, A., Platnich, J. M., Hughes, P. F., Muruve, D. A., Haystead, T., & MacDonald, J. A. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.12.031 · Cited by 22

Pyroptosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential

Tang, T. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01579-5 · Cited by 17

What type of cell death occurs in chronic cerebral hypoperfusion? A review focusing on pyroptosis and its potential therapeutic implications

He, Y., Chen, X., Wu, M., Hou, X., & Zhou, Z. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1073511 · Cited by 19

Glyburide inhibits the bone resorption induced by traumatic occlusion in rats

Arita, Y., Yoshinaga, Y., Kaneko, T., Kawahara, Y., Nakamura, K., Ohgi, K., Arita, S., Ryu, T., Takase, M., & Sakagami, R. (2020) · Journal of Periodontal Research · doi:10.1111/jre.12731 · Cited by 17

Study of the correlation between the noncanonical pathway of pyroptosis and idiopathic inflammatory myopathy

Ma, M., Chai, K.-X., & Deng, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107810 · Cited by 17

Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione

Kewcharoenwong, C., Rinchai, D., Nithichanon, A., Bancroft, G. J., Ato, M., & Lertmemongkolchai, G. (2016) · Scientific Reports · doi:10.1038/srep34794 · Cited by 17

The Secreted Virulence Factor NADase of Group A Streptococcus Inhibits P2X7 Receptor-Mediated Release of IL-1β

Westerlund, E., Valfridsson, C., Yi, D. X., & Persson, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01385 · Cited by 17

NLRP3 inflammasome: structure, mechanism, drug-induced organ toxicity, therapeutic strategies, and future perspectives

Singh, D. D. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00167f · Cited by 19

JC124 confers multimodal neuroprotection in epilepsy by suppressing NLRP3 inflammasome activation: evidence from animal and human neuronal models

Zhang, P., Li, Z., Liang, M., Yuan, J., Zhou, J., Zhang, J., Deng, J., Chen, Y., Tang, H., Xu, C., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02239-3 · Cited by 17

Targeting the NLRP3 inflammasome in sepsis: Molecular mechanisms and therapeutic strategies

Ma, Y., Meng, J., Sun, F., & Lei, M. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.09.006 · Cited by 17

Disruption of the lipolysis pathway results in stem cell death through a sterile immunity-like pathway in adult Drosophila

Aggarwal, P., Liu, Z., Cheng, G. Q., Singh, S. R., Shi, C., Chen, Y., Sun, L. V., & Hou, X. S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110958 · Cited by 17

Targeting the inflammasome in rheumatic diseases

McCoy, S. S., Stannard, J. N., & Kahlenberg, J. M. (2015) · Translational research · doi:10.1016/j.trsl.2015.06.006 · Cited by 16

A novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure

Hao, J., Li, Y., & Li, R. S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2012.12.041 · Cited by 16

Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome

Matico, R., Grauwen, K., Chauhan, D., Yu, X., Abdiaj, I., Adhikary, S., Adriaensen, I., Aranzazu, G. M., Alcázar, J., Bassi, M., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00181-4 · Cited by 15

Targeting the NLRP3 inflammasome for calcium oxalate stones: pathophysiology and emerging pharmacological interventions

Boldt, A. M., & Sole, F. D. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1614438 · Cited by 17

Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity

Lin, W., Li, L., Hsiao, Y.-Y., Wong, W.-T., Chiu, H., Hsu, H.-T., Peng, Y., Ho, C., Chernikov, O. V., Cheng, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870627 · Cited by 15

The treatment of melioidosis: is there a role for repurposed drugs? A proposal and review

Laws, T. R., Taylor, A. W., Russell, P., & Williamson, D. E. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1496330 · Cited by 15

Colchicine Does Not Reduce Abdominal Aortic Aneurysm Growth in a Mouse Model

Phie, J. K. P., Thanigaimani, S., Huynh, P., Anbalagan, R., Moran, C. S., Kinobe, R. T., Moxon, J. V., Field, M. A., Krishna, S. M., & Golledge, J. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/5299370 · Cited by 15

Neohesperidin dihydrochalbazone protects against septic acute kidney injury in mice

Yang, R., Qi, L., & Liang, W. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154623 · Cited by 15

Sulphonylurea Usage in Melioidosis Is Associated with Severe Disease and Suppressed Immune Response

Liu, X., Foo, G. T. T., Lim, W. P., Ravikumar, S., Sim, S. H., Win, M. S., Goh, J. G., Lim, J. H. J., Ng, Y. H., Fisher, D. A., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002795 · Cited by 15

Role of Dectin‐1 receptor on cytokine production by human monocytes challenged with Paracoccidioides brasiliensis

Romagnolo, A. G., Silva, J. C. D. Q. E., Coletta, A. M. D., Gardizani, T. P., Martins, A. T. L., Romagnoli, G. G., Kaneno, R., Soares, Â. M. V. D. C., Faveri, J. D., & Dias‐Melicio, L. A. (2017) · Mycoses · doi:10.1111/myc.12725 · Cited by 17

Small molecule inhibitors of NLRP3 inflammasome and GSK-3β in the management of traumatic brain injury: A review

Ghouse, S. M., Joshi, S. V., Akunuri, R., Rana, P., Rahman, Z., Polomoni, A., Yaddanapudi, V. M., Dandekar, M. P., & Nanduri, S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115718 · Cited by 15

Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer

Hamza, S., Garanina, E. E., Shkair, L., Al-Saadi, A., Khaiboullina, S. F., & Tezcan, G. (2024) · Pharmaceuticals · doi:10.3390/ph17030299 · Cited by 16

Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer’s disease

Tantra, T., A, A. R. T., Nandini, N., & Chaudhary, S. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107912 · Cited by 14

Characterization of equine inflammasomes and their regulation

Ahn, H., Kim, J., Lee, H., Lee, E., & Lee, G. (2020) · Veterinary Research Communications · doi:10.1007/s11259-020-09772-1 · Cited by 14

Pharmacological targeting of microglia dynamics in Alzheimer’s disease: Preclinical and clinical evidence

Yousefizadeh, A., Piccioni, G., Saidi, A., Triaca, V., Mango, D., & Nisticò, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106404 · Cited by 15

Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats

dos Santos, R. M. S., Oliveira, S. M., Silva, C. R., Hoffmeister, C., Ferreira, J., & Assreuy, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0615-2 · Cited by 13

Toll-like receptor 4-interacting SPA4 peptide suppresses the NLRP3 inflammasome in response to LPS and ATP stimuli

Ramani, V., & Awasthi, S. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1114-570r · Cited by 14

The role of the inflammasome and its related pathways in ovarian cancer

Liu, C., Huang, X., & Su, H. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02805-y · Cited by 15

Role of inflammasomes in endothelial dysfunction

Wu, J., Shyy, M., Shyy, J. Y. ‐., & Xiao, H. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16479 · Cited by 14

Advancing personalised precision treatment for Still's disease based on molecular characteristics and disease progression

Shen, Y., Jia, J., Teng, J., Yang, C., & Hu, Q. (2024) · The Lancet Rheumatology · doi:10.1016/s2665-9913(24)00225-x · Cited by 13

Triggers of NLRC4 and AIM2 inflammasomes induce porcine IL-1β secretion

Ahn, H., Kim, J., Kwon, S., Kim, P.-H., Kwon, H. M., Lee, E., & Lee, G. (2018) · Veterinary Research Communications · doi:10.1007/s11259-018-9729-x · Cited by 13

Interaction among inflammasome, autophagy and non-coding RNAs: new horizons for drug

Pu, Q., Lin, P., Wang, Z., Gao, P., Qin, S., Cui, L., & Wu, M. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz019 · Cited by 13

Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors

Wang, X., Liu, Y., Han, X., Zou, G., Zhu, W., Shen, H. C., & Liu, H. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128101 · Cited by 13

Ex Vivo Lung Perfusion with K(ATP) Channel Modulators Antagonize Ischemia Reperfusion Injury

Arni, S., Maeyashiki, T., Latshang, T. D., Opitz, I., & İnci, İ. (2021) · Cells · doi:10.3390/cells10092296 · Cited by 13

Regulatory Mechanisms Controlling Inflammation and Synthesis of Acute Phase Proteins

Jura, J., & Koj, A. (2011) · InTech eBooks · doi:10.5772/18207 · Cited by 13

Les inflammasomes et les maladies humaines

Jamilloux, Y., Sève, P., & Henry, T. (2014) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2014.04.017 · Cited by 15

Future Directions of Cytokine Hypothesis in Depression: ‘NLRP3 inflamazomu’

Şahin, C., & Arıcıoğlu, F. (2013) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20130927070724 · Cited by 13

Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes

Cull, A. H., & Rauh, M. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ri0317-083r · Cited by 13

A strategy to find novel candidate anti-Alzheimer’s disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants

Chen, B., Li, W., Wang, G., Li, G., Liu, J.-Q., Zheng, J., Wang, Q., Li, H., Dai, S., & Huang, J. (2018) · PeerJ · doi:10.7717/peerj.4756 · Cited by 13

Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer’s disease

Lee, H., & Kim, E. Y. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01268-5 · Cited by 14

Introduction to Autoinflammatory Syndromes and Diseases

Abramovits, W., & Oquendo, M. (2013) · Dermatologic Clinics · doi:10.1016/j.det.2013.04.010 · Cited by 13

Inflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies

Scalavino, V., Piccinno, E., Giannelli, G., & Serino, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313058 · Cited by 13

Current development in sulfonamide derivatives to enable CNS-drug discovery

Blicharz-Futera, K., Kamiński, M., Grychowska, K., Canale, V., & Zajdel, P. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108076 · Cited by 13

NLRP3 Inflammasome in Autoinflammatory Diseases and Periodontitis Advance in the Management

Hashim, N. T., Babiker, R. A., Mohammed, R., Rehman, M. M., Chaitanya, N. C., & Gismalla, B. G. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1118_23 · Cited by 12

Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome

Maeda, T., Shirakami, Y., Taguchi, D., Miwa, T., Kubota, M., Sakai, H., Ibuka, T., Mori, K., Tomita, H., & Shimizu, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111640 · Cited by 12

Development of NLRP3 Inflammasome Inhibitors

Blevins, H. (2022) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/wk7f-1g56

Cryopyrin: A Specific Activator of the Inflammasome

(2006) · Science s STKE · doi:10.1126/stke.3262006tw93

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders

Jiang, H., He, H., Chen, Y., Huang, W., Cheng, J., Ye, J., Wang, A., Tao, J., Wang, C., Liu, Q., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20171419 · Cited by 783

The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and

Inflammasomes, A., Coll, R. C., & O’neill, L. A. J. (2011)

A natural product inhibitor of the NLRP3 inflammasome derived from Glycyrrhiza uralensis for the treatment of inflammatory diseases

Yang, G., Lee, H., Han, S., An, T.-J., Jang, J.-K., & Lee, J. Y. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.198.supp.138.3 · Cited by 3